Finland· FI-REL-REL403
Celeston Chronodose
A betamethasone product containing betamethasone acetate + betamethasone sodium phosphate, registered in Finland by N.V. Organon. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Betamethasone is registered in 12 of 19 countries.
Countries holding a registration under ATC H02AB01 (betamethasone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Betamethasone · ATC H02AB01
12 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of betamethasone costs, country by country.
Normalised to the WHO defined daily dose (1.5 mg), the median price runs from $0.34 in Italy to $1.42 in Switzerland — a ×4.1 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Betamethasone · price per daily dose (1.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.42
- IT Italy$0.34
The record
At a glance
Fimea (Finland)- Active substance
- Betamethasone acetate + Betamethasone sodium phosphate
- Manufacturer
- N.V. Organon
- Country
- Finland (FI)
- ATC code
- H02AB01
- ATC class
- Betamethasone
- Defined daily dose
- 1.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
509 interactions on record for betamethasone.
Graded by severity as the source publishes them — 55 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Betamethasone · interactions on record
509 records
- 55 severe
- 391 moderate
- 43 minor
Most severe, free to view
- DesirudinB01AE01severe
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- AprepitantA04AD12moderate
20 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Betamethasone in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBetaloan SUIKAsclemed USA, Inc.
- GermanyCelestan DepotOrganonhealthcare Gmbh
- NorwayCelestan DepotOrganon Healthcare GmbH
- IcelandDiprospanN.V. Organon*
- SwedenCeleston bifas 5,7 mg/ml Injektionsvätska, suspensionNV Organon
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Celestan Biphase, Diprophos
- Belgium · Celestone Chronodose, Diprophos Ampoule
- Bulgaria · Дипрофос
- Germany · Celestan Depot, Diprosone Depot 1 Ml Ampulle
- Denmark · Diprospan
- Spain · Celestone Cronodose
- France · Celestene Chronodose, Diprostene
- Greece · Celestone Chronodose, Propiochrone
- Hungary · Diprophos
- Iceland · Diprospan
- Luxembourg · Celestone Chronodose, Diprophos Ampoule
- Netherlands · Celestone Chronodose
- Norway · Celeston Chronodose
- Poland · Diprophos
- Portugal · Diprofos Depot
- Romania · Diprophos
- Sweden · Celeston Bifas
- Slovakia · Diprophos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/13045604-4832-4aa8-8a4d-cbecd16a446a GET /v1/drugs/13045604-4832-4aa8-8a4d-cbecd16a446a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.4",
"form": "injektioneste, suspensio",
"route": "Niveltä ympäröivään kudokseen",
"ddd_unit": "mg",
"strength": "(3+3) mg/ml",
"atc_label": "beetametasoni",
"ma_number": "3677",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL403",
"authorised_at": "1966-07-06"
}See everything about betamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.